Peptides studied for tissue repair, cellular recovery, and regenerative research applications.
Sort by
Display
per page
BAM15 selective mitochondrial protonophore uncoupler. N5,N6-bis(2-fluorophenyl)-oxadiazolopyrazine-diamine, C₁₆H₁₀F₂N₆O, 340.29 Da, CAS 210302-17-3. EC₅₀ 270 nM. No plasma membrane depolarization. ≥98% purity. Lab research only.
MK-677 (Ibutamoren) oral GHS-R1a ghrelin receptor agonist. Non-peptide growth hormone secretagogue with ~24h half-life. C₂₇H₃₆N₄O₅S, 528.67 Da, CAS 159752-10-0. ≥98% purity. Laboratory research only.
SLU-PP-332 pan-ERRα/β/γ agonist exercise mimetic. (E)-4-Hydroxy-N'-(naphthalen-2-ylmethylene)benzohydrazide. EC₅₀: ERRα 98 nM, ERRβ 230 nM, ERRγ 430 nM. C₁₈H₁₄N₂O₂, 290.32 Da, CAS 303760-60-3. ≥98% purity. Lab research only.
- Synthetic mitochondria-targeted tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) that selectively concentrates 5,000-fold at inner mitochondrial membrane through high-affinity cardiolipin binding
- FDA-approved September 2025 as Forzinity for Barth syndrome — first FDA-approved mitochondria-targeted therapeutic
- Extensively validated in 200+ peer-reviewed publications spanning cardiac, renal, neurological, and musculoskeletal research; multiple Phase 2/3 clinical trials completed
- Nonapeptide (DSIP): 9-amino acid sequence (WAGGDASGE), ≥98% purity by HPLC
- Slow-Wave EEG Modulator: Delta-band activity research in neocortex and limbic cortex
- Mitochondrial Studies: Hypoxia-stress respiration research in rat brain models
- Leucine Dipeptide: Two L-leucine residues (Leu-Leu), 244.33 Da, ≥98% purity
- PEPT1 Transport System: Active absorption via proton-coupled peptide transporter in small intestine
- Muscle Protein Synthesis: Enhanced mTORC1 activation and 42% greater anabolic response versus free leucine
